Malignant peripheral nerve sheath tumor is a malignant neoplasm that is rarely found in the oral cavity. About 50% of this tumor occurs in patients with neurofibromatosis type I and comprises approximately 10% of all soft tissue sarcomas of head and neck region. Intraosseous malignant peripheral nerve sheath tumor of the maxilla is rare. This article is the first to address malignant peripheral nerve sheath tumor of the maxilla presenting as a periapical radiolucency on nonvital endodontically treated teeth in the English medical literature. Surgical approaches to malignant soft tissue tumor vary based on the extent of the disease, age of the patient, and pathological findings. A rare case of intraosseous malignant peripheral nerve sheath tumor is reported in a 16-year-old woman. The patient presented clinically with a pain involving the upper left incisors region and with defined unilocular periapical radiolucency lesion involved between the upper left incisors. An incisional biopsy was made. Histological and immunohistochemical examination were positive for S-100 protein and glial fibrillary acidic protein showed that the lesion was an intraosseous malignant peripheral nerve sheath tumor of the maxilla. Nine years after the surgery, no regional recurrence was observed.
Introduction
Malignant peripheral nerve sheath tumor (MPNST) is a malignant neoplasm that is rarely found in the oral cavity. About 50% of this tumor occurs in patients with neurofibromatosis type 1 (NF-1) and comprises approximately 10% of all soft tissue sarcomas of both head and neck region [1] . Its incidence in the oral region is extremely low, roughly 0,001% [2] . Its occurrence in head and neck regions involves soft and hard tissues [3] . However, intraosseous maxillary MPNST presenting as a periapical lesion is exceptionally unusual. This tumor type occurs in peripheral nerves and may exhibit differentiation in nerve sheath elements such as Schwann cells and perineural cells, as well as fibroblasts [1] . The differential diagnosis of this neoplasm may be facilitated by additional information obtained from immunohistochemistry findings [2] .
This article reports the unusual clinical case of intraosseous MPNST with no association with NF-1, presenting as a periapical lesion on nonvital endodontically treated teeth.
Case Presentation
A 16-year-old female was referred with pain involving the upper left incisors region. Patient history revealed endodontic treatment of the maxillary upper left incisors with necrotic pulp and periapical radiolucency six months earlier. A few months after the treatment, she experienced discomfort pain. Extraoral examination revealed an integrate mucosa with normal appearance, whereas, intraorally, the upper left lateral incisor presented chromatic alterations and mobility in the region. A periapical radiograph showed the presence of a defined radiolucency lesion between the upper left incisors of the endodontically treated teeth with a size of 2.5 × 1.0 cm in a high diameter (Figure 1 ). An incisional biopsy was made using local anesthesia and sent to the Oral Pathology Laboratory. The specimen was fixed in 10% neutral formalin and routinely prepared for light microscopy; the sections were stained with hematoxylin and eosin. Histological examination showed malignant neoplasm fragments consisting of fusiform cells with comma-shaped nuclei, originating from cell bundles exhibiting one of two forms: a round shape with large nuclei (occasionally palisading) or hyalinized strands and/or islets (Figures 2(a) and 2(b) ). Immunohistochemistry analysis was performed using streptavidin-biotin technique with monoclonal antibodies; the cells were positive for both the S-100 protein and the glial fibrillary acidic protein (GFAP) (Figures 2(c) and 2(d)). The immunohistochemical expression of protein S-100 was weak at less than 50% of the tumor cells (Figure 2 
Discussion
This paper describes an unusual case of intraosseous maxillary MPNST mimicking a periapical lesion in order to call attention of clinicians to the fact that several different diseases are able to mimic endodontic periapical lesions. The available literature shows that there are no reports of this tumor presenting as periapical lesion in the upper left incisors. It also shows the complexity of a diagnosis of rare bone tumors when based on clinical and radiographic features only. Besides, MPNST onset occurs in a peripheral nerve that may exhibit differentiation of nerve sheath elements, which is more common in the proximal extremities and stem of the nerve [4] . Although uncommon, occurrence in cranial nerves usually targets the fiftieth cranial nerve pair [1] .
Patient history, clinical examinations, pulp sensitivity tests, and endodontic treatment follow-up are essential for the diagnosis of inflammatory periapical lesions. The presence of periapical images and dental resorption are characteristic of endodontic and/or odontogenic origin lesions. Soft tissue tumor diagnoses are extremely difficult, and diagnosis of MPNST is particularly difficult because it lacks diagnostic criteria. Although no consensus exists regarding the classification of sarcomas as a type of MPNST, the reported lesion could be placed in this category because its onset occurred in a peripheral nerve or neurofibroma, and it fulfilled one of the three established diagnosis criteria, which include (1) the tumor originating in a peripheral nerve that does not exhibit lines of aberrant or heterologous differentiation; (2) the tumor originating from a preexisting benign nerve sheath tumor, usually a neurofibroma; or (3) the tumor exhibiting characteristics that are commonly observed in tumors originating from the aforementioned situations or malignant Schwann cell tumors [2, 3] . The present case fulfills the diagnostic criterion of MPNST onset occurring in a peripheral nerve.
Despite imaging features of MPNST being nonspecific and noncharacteristic, the role of radiologic diagnosis is to ensure that MPNST are preoperatively suggested as a diagnosis and are differentiated from malignant lesions through a series of specific imaging findings. It is important to highlight the aggressiveness of the lesion by a radiographic examination, once it is required to analyze bone destruction, extra bone invasion, structure of the lesion, and root resorption [5] .
Radiographic findings of intraosseous MPNST may show a great variation, from unilocular to multilocular, with or without well-defined borders of the lesion, and cortical expansion. Periapical radiographs of the presenting case of intraosseous MPNST showed a unilocular periapical lesion with a defined border and external dental resorption in the lateral region and apical region of upper left incisors. This radiographic appearance was suggestive of a periapical lesion of cyst, once external root resorption does not occur exclusively of malignancies, as what may occur for orthodontic movement, neoplasia, being more common in case of inflammatory origin, such as periapical lesion [5] .
Establishing a diagnosis requires immunohistochemistry technique because MPNST may be similar to fibrosarcoma. And a plethora of other bone tumors are included in differential diagnoses such as central giant cell lesion, fibrous dysplasia, ameloblastoma, myxoma, haemangioma, neurofibroma, leiomyoma, sarcoma, or simply periapical lesions [1] . It is also essential to include S-100 protein for suspected neural tumors, since it is positive in all neural tumors [6] . And the use of GFAP refers to filament proteins type III intermediate and it is the essential component of the cytoskeleton in astrocytes of all vertebrates [7] . However, the latter exhibits irregularly shaped cells. These tumors also exhibit characteristics such as regular Schwann cells, with dense and hypodense fascicles creating a marbleized effect and myxoid areas; elongated, asymmetric cone-shaped cells with irregular, palisading, and comma-or buckle-shaped nuclei; spiral structures; peculiar hyperplastic perivascular alterations; and, occasionally, heterologous elements (cartilage, bone, and muscle, which are present in 10-15% of tumors). These tumors may exhibit a greater degree of cellular differentiation, pleomorphism, and mitotic activity [3] .
Malignant peripheral nerve sheath tumors were most commonly located on the extremities (45%), then trunk (34%), and head and neck region (19%) [8] . In head and neck region, they occur most frequently in both nasopharynx and the nasal cavity [9] . The absence of such reports confirms the difficulty of performing differential diagnoses of periapical pathologies because tumors can mimic an inflammatory periapical lesion. The recommended treatment option for MPNST is surgical excision. However, it is a difficult procedure due to poor anatomical accessibility and its probability of recurrence varies approximately between 40 and 65% in head and neck region and approximately between 40 and 68% elsewhere [4] . Surgical approaches to malignant soft tissue tumor vary based on the extent of the disease, age of the patient, and pathological findings. Yet, surgical excision with wide margins is the first treatment choice for the majority of patients. Radiation and/or chemotherapy may also be used due to the high recurrence rates or in the case of an incomplete lesion excision. Adjuvant radiation and/or chemotherapy treatment must always be considered and guided by the clinical stage [10, 11] . Nonetheless, in the case reported, the patient opted for surgical excision in conjunction with chemotherapy. The patient responded well to the treatment and was disease-free at the nine-year control follow-up evaluation.
To establish the diagnoses of MPNST, it requires immunohistochemistry technique. Radiographically, maxillary intraosseous MPNST is difficult to differentiate from other bone lesions. The differential diagnosis of the case presented in this article included periapical inflammatory lesions, such as periapical granuloma or cyst. The root resorption is not a usual finding of the above lesions. Root resorption can be seen in central giant cell granuloma or an odontogenic neoplasm such as ameloblastoma or in malignant tumors. Nine years after the surgery, no regional recurrence was observed.
